Skip Navigation
Print This Page
Share this page: More


 April 2015

Announcement of Solicitation Subaward

Sally McFall, PhD of Northwestern University, located in Evanston, Illinois, has been awarded a contract to support the adaptation of an FDA-approved platform from a commercial source to create a new point-of-care test for chlamydia, and to develop a method to extract swabs and urine for use with this platform. 

October 2014

Announcement of Solicitation Subaward

Lavance Northington, MBA and Chief Executive of Cellgen Diagnostics, whose headquarters are located in Irvine, California, has been awarded a contract to develop a point-of-care test for chlamydia on its genetic microarray platform capable of multiplex analysis for chlamydia.

August 2014

Announcement of Solicitation Subaward

James Mahony, PhD of McMaster University, located in Ontario, Canada, has been awarded a contract to integrate the Paratus Sample Delivery System with their proprietary LAMP assay to create a hand-held sample-to-result point-of-care test for chlamydia. The resultant integrated test is expected to be fully CLIA waivable.

June 2014

Announcement of Solicitation Subaward:

John Carrano, PhD and CEO of Paratus Diagnostics LLC, whose headquarters are located in Austin, Texas, has been awarded a contract to develop their Specimen Delivery System (SDSTM) for integration with a detection platform for chlamydia. The device extracts, lyses and delivers protein or clean nucleic acid for amplification as needed by the detection platform.


Announcement of Solicitation Subaward:

Atlas Genetics Ltd., a UK-based healthcare company focused on providing rapid DNA diagnostics, was awarded a contract to adapt their testing platform into a point-of-care system for diagnosis of chlamydia infections.

Atlas Genetics

►► View the PDF of Atlas Genetic's poster here


Announcement of Solicitation Subaward:

Meso Scale Diagnostics LLC, whose headquarters are located in Gaithersburg, Maryland, was awarded a contract to adapt their diagnostic testing platform into a point-of-care system for diagnosis of chlamydia infections. This award for development of a novel point-of-care test was made based on a review by a team of experts in the fields of medical technology, sexually transmitted disease and fieldable diagnostics. 

Announcement of ARRA Supplement for Comparative Effectiveness Research: 

An award issued under the American Recovery and Reinvestment Act (ARRA) of 2009 was sub-contracted to Diane R. Blake, MD at the University of Massachusetts Medical School.  Dr Blake and graduate student Wei (Tiffany) Huang, in collaboration with Dr. Gaydos,  developed a comparative-effectiveness research (CER) model for clinic-based point-of-care Chlamydia tests versus standard Chlamydia tests, and for Internet-based POC and standard tests versus clinic-based POC and standard tests.  Outcomes of this CER project provide guidance to public health officials for future recommendations of the most effective manner in which to address the chlamydia epidemic and prevent its sequelae.



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.